At the 8mg dose, participants lost an average of 21.6kg of fat mass compared to placebo
Although some observational studies suggest that GLP-1RAs protect against arrhythmias, the evidence remains inconclusive
Centered on patient needs and innovation, Innovent has established and will continue to expand its rich CVM pipeline with mazdutide as a cornerstone product, aiming to continuously address the public's growing demand for health and quality of life and to serve more patients." About Obesity/Overweight Obesity is a chronic metabolic disease with complex causes, and it serves as a major risk factor for a range of diseases including diabetes, fatty liver disease, cardiovascular and cerebrovascular diseases, kidney disease, joint disorders, sleep-disordered breathing, and cancer
All other data are not publicly available because of the lack of public databases for these data formats but are available from the corresponding author on reasonable request
When PI3 kinase inhibitors were added, the anti-apoptotic effect of GLP-1 was also abolished (GLP-1 + LY294002 + MG: 0% early apoptosis, 3.06% late apoptosis
However, the initial production method was not only complicated, costly and low-yielding, but also susceptible to immune reactions and viral infections
